TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,000 | -69.9% | 53,080 | +128.1% | 0.00% | -100.0% |
| Q2 2018 | $83,000 | -82.0% | 23,273 | -68.2% | 0.00% | -87.5% |
| Q4 2017 | $460,000 | +114.0% | 73,076 | +132.0% | 0.01% | +100.0% |
| Q3 2017 | $215,000 | -47.7% | 31,497 | -45.4% | 0.00% | -50.0% |
| Q2 2017 | $411,000 | +263.7% | 57,663 | +369.5% | 0.01% | +166.7% |
| Q1 2017 | $113,000 | +36.1% | 12,283 | -40.5% | 0.00% | 0.0% |
| Q4 2016 | $83,000 | -69.6% | 20,652 | -65.0% | 0.00% | -85.7% |
| Q1 2016 | $273,000 | +6.2% | 58,931 | +129.2% | 0.02% | -25.0% |
| Q4 2015 | $257,000 | – | 25,709 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |